Long-term observational studies suggest substantial reductions in all-cause mortality
These findings have provided valuable insights into the management of T2D and informed clinical practice guidelines and regulatory decisions.GLP-1 receptor agonists have emerged as an important therapeutic option for individuals with T2D, particularly those at high risk of CVD
Benefit: Gut Health Focus Area: Leaky Gut, IBD, Ulcers Mechanism of Action: Repairs the mucosal lining and maintains intestinal barrier integrity
For tirzepatide (Zepbound, Mounjaro), FDA labeling advises discontinuation at least one month before planned pregnancy, reflecting its half-life of approximately five days
BPC-157 Benefits | Clinical Trials Researchers have identified numerous potential benefits of BPC-157 in both laboratory animal and human studies, although the evidence available in humans is extremely limited at this time
In that same report, the FDA also noted that some compounders may be using salt forms of semaglutide